⌘+K

October 1, 2021Open Access

Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study

Key Points

Key points are not available for this paper at this time.

Abstract

Combination of LEN, PD-1 and TACE showed a high rate of tumor response and convert resection in uHCC patients, with manageable toxicity.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Jiayi Wu

Zhejiang Chinese Medical University

Zhenyu Yin

Nanjing University of Chinese Medicine

Yannan Bai

Fujian Medical University

Journals

SHILAP Revista de lepidopterología

Journal of Hepatocellular Carcinoma

Actions

Institutions

Fujian Medical University

First Affiliated Hospital of Xiamen University

Zhongshan Hospital of Xiamen University

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

Wu et al. (Fri,) studied this question.

synapsesocial.com/papers/69d8e7a113e0539d74bedfed — DOI: https://doi.org/10.2147/jhc.s332420

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

The role of hepatic resection in the treatment of hepatocellular cancer· 2015 · 412 citations
Non‐surgical treatment of hepatocellular carcinoma· 2005 · 46 citations
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma· 2020 · 7,181 citations
Hepatocellular Carcinoma· 2019 · 4,642 citations
A New Treatment Option for Intermediate-Stage Hepatocellular Carcinoma with High Tumor Burden: Initial Lenvatinib Therapy with Subsequent Selective TACE· 2019 · 159 citations

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

The role of hepatic resection in the treatment of hepatocellular cancer· 2015 · 412 citations
Non‐surgical treatment of hepatocellular carcinoma· 2005 · 46 citations
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma· 2020 · 7,181 citations
Hepatocellular Carcinoma· 2019 · 4,642 citations
A New Treatment Option for Intermediate-Stage Hepatocellular Carcinoma with High Tumor Burden: Initial Lenvatinib Therapy with Subsequent Selective TACE· 2019 · 159 citations

Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study

Also consider

Also consider